260 related articles for article (PubMed ID: 6330251)
1. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
2. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Hershfield MS; Kredich NM
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
[TBL] [Abstract][Full Text] [Related]
3. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
Palella TD; Schatz RA; Wilens TE; Fox IH
J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
[TBL] [Abstract][Full Text] [Related]
4. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
Boss GR; Pilz RB
J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
6. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
Mitchell BS; Edwards NL
J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
8. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes.
Kefford RF; Helmer MA; Fox RM
Cancer Res; 1982 Sep; 42(9):3822-7. PubMed ID: 6980705
[No Abstract] [Full Text] [Related]
10. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
11. Purine nucleoside kinases in human T- and B-lymphoblasts.
Yamada Y; Goto H; Ogasawara N
Biochim Biophys Acta; 1983 Nov; 761(1):34-40. PubMed ID: 6315069
[TBL] [Abstract][Full Text] [Related]
12. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
Wortmann RL; Mitchell BS; Edwards NL; Fox IH
Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
[TBL] [Abstract][Full Text] [Related]
13. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
[TBL] [Abstract][Full Text] [Related]
14. The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemia.
Hallam LJ; Van der Weyden MB; Ackland SP; Bagnara AS; Whiteside MG
Scand J Haematol; 1984 Jan; 32(1):55-64. PubMed ID: 6607510
[TBL] [Abstract][Full Text] [Related]
15. Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine.
Hershfield MS
J Biol Chem; 1979 Jan; 254(1):22-5. PubMed ID: 309884
[TBL] [Abstract][Full Text] [Related]
16. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
[TBL] [Abstract][Full Text] [Related]
17. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
Mann GJ; Fox RM
J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
[TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase.
Kamatani N; Willis EH; Carson DA
Biochim Biophys Acta; 1983 Apr; 762(2):205-14. PubMed ID: 6600937
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside kinases in T and B lymphoblasts distinguished by autoradiography.
Osborne WR
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4030-4. PubMed ID: 3012544
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of equine S-adenohomocysteine hydrolase by 2'-deoxyadenosine.
Magnuson NS; Perryman LE; Decker DM; Magnuson JA
Int J Biochem; 1984; 16(11):1163-5. PubMed ID: 6335439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]